Producer
Indian Government Opium & Alkaloid Works (GOAW)
The Government Opium and Alkaloid Works (GOAW) operates India's two state-owned opium processing factories: the Ghazipur Opium and Alkaloid Works (Uttar Pradesh) and the Neemuch Alkaloid Works (Madhya Pradesh), both operating under the Narcotics Commissioner of India and Ministry of Finance. India is the world's largest licit opium producer by cultivation area — approximately 17,000 hectares in Rajasthan's Mewar and Nimbahera districts, plus Madhya Pradesh — producing under strict INCB licensing. The Ghazipur and Neemuch factories process raw opium into codeine phosphate, morphine, and limited thebaine for pharmaceutical export. India's codeine phosphate production (for the global OTC cough syrup market) is particularly significant — India supplies a substantial fraction of the global codeine phosphate API market. The state ownership structure means GOAW's alkaloid production is directly tied to Indian government licensing decisions, Rajasthan monsoon success, and bilateral pharmaceutical trade agreements.
1
Inputs supplied
1
Goods downstream
1
Facilities
0
Stories
What they make
1 input Indian Government Opium & Alkaloid Works (GOAW) supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Indian Government Opium & Alkaloid Works (GOAW) makes, pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
Morphine API Export
45%Codeine API Export
30%Other Opioid Alkaloid Processing
25%
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Origin2023
The Ghazipur Opium and Alkaloid Works was established by the British East India Company in 1820 on the Ganges River to process opium from Uttar Pradesh poppy fields for export to China — the trade that triggered the First (1839) and Second (1856) Opium Wars and helped establish British imperial dominance in East Asia. Ghazipur is one of the oldest continuously operating pharmaceutical manufacturing facilities in the world, if the colonial drug trade is counted alongside its modern pharmaceutical function. After Indian independence, the factories were nationalized under India's Narcotics Commissioner and reoriented to supply pharmaceutical-grade morphine and codeine for licit global pharmaceutical markets.
Narcotics Control Bureau, India ↗Concentration2022
The Ghazipur Opium and Alkaloid Works in Uttar Pradesh, India was established in 1820 under the British East India Company as a processing facility for opium destined for the 19th-century opium trade with China — the same trade that triggered the First and Second Opium Wars (1839-1842, 1856-1860). The Ghazipur factory has been in continuous operation for over 200 years, making it likely the world's oldest continuously operating pharmaceutical narcotics processing facility. It processed opium for the British colonial export trade, for World War II morphine supplies, and now processes Rajasthan farmers' licit opium into codeine phosphate for global pharmaceutical markets under Indian government ownership. The factory's 19th-century buildings coexist with modern pharmaceutical processing equipment. India's poppy farmers in Rajasthan still grow under a government licensing system that traces directly to British colonial opium monopoly regulations — opium cultivation in Rajasthan requires a specific area-based license from the Narcotics Commissioner of India, a bureaucratic structure inherited from the East India Company's opium management system.
Government of India, Narcotics Control Bureau ↗Did you know2023
India's GOAW factories supply morphine to global pharmaceutical markets — where morphine is on the WHO Model List of Essential Medicines as a critical palliative care drug, and global access to affordable morphine for cancer pain management is a major public health concern (most developing countries have severely restricted morphine access). The same Indian state factories also supply codeine, which appears in the consumer over-the-counter cough medicine supply chain globally. WHO palliative care advocates, developing-world oncology organizations, and consumer cold medicine manufacturers all source from the same Indian government opium processing factories that were originally built by the East India Company to profit from Chinese opium addiction.
World Health Organization ↗